123 related articles for article (PubMed ID: 31832406)
1.
Anayama T; Taguchi M; Tatenuma T; Okada H; Miyazaki R; Hirohashi K; Kume M; Matsusaki K; Orihashi K
World J Clin Cases; 2019 Dec; 7(23):4036-4043. PubMed ID: 31832406
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.
Hisakane K; Ohmatsu H; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Goto K
J Nippon Med Sch; 2017; 84(5):231-236. PubMed ID: 29142184
[TBL] [Abstract][Full Text] [Related]
3. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
[TBL] [Abstract][Full Text] [Related]
4. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
6. Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: case reports.
Kawaguchi M; Banno K; Susumu N; Yanokura M; Kuwabara Y; Hirao N; Tsukazaki K; Nozawa S
Anticancer Res; 2005; 25(5):3547-51. PubMed ID: 16101178
[TBL] [Abstract][Full Text] [Related]
7. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
[TBL] [Abstract][Full Text] [Related]
8. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.
Maeda O; Ando T; Ishiguro K; Watanabe O; Miyahara R; Nakamura M; Funasaka K; Kazuhiro F; Ando Y; Goto H
Mol Clin Oncol; 2014 Nov; 2(6):1103-1106. PubMed ID: 25279205
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
[TBL] [Abstract][Full Text] [Related]
11. Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report.
Huang X; Hong Y; Xie SY; Liao HL; Huang HM; Liu JH; Long WJ
World J Clin Cases; 2022 Oct; 10(28):10317-10325. PubMed ID: 36246798
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
Fukunaga S; Egawa M; Ito T; Tanabe K
J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
[TBL] [Abstract][Full Text] [Related]
13. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
[TBL] [Abstract][Full Text] [Related]
14. Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.
Matsusaki K; Orihashi K
Artif Organs; 2020 Oct; 44(10):1090-1097. PubMed ID: 32242939
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance.
Akahane T; Hirasawa A; Imoto I; Okubo A; Itoh M; Nanki Y; Yoshihama T; Tominaga E; Aoki D
Hum Cell; 2020 Jan; 33(1):272-282. PubMed ID: 31583526
[TBL] [Abstract][Full Text] [Related]
16. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
17. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
18. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
[TBL] [Abstract][Full Text] [Related]
20. Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report.
Tsukishiro Y; Yamamoto H; Masumoto A; Takaya T
Eur Heart J Case Rep; 2023 Mar; 7(3):ytad081. PubMed ID: 36895305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]